Triangle Business Journal Biogen ends two key drug trials, raising stakes for Alzheimer's drug North Carolina Business • Oct 21, 2020
Triangle Business Journal Biogen's Boston meeting may have led to 20,000 Covid cases, report says North Carolina Business • Aug 25, 2020
Triangle Business Journal Biogen's Alzheimer's drug isn't FDA-approved yet, but it may already have a name North Carolina Business • Aug 10, 2020
Triangle Business Journal Iqvia CFO leaves for Biogen: Here's how much more he'll be paid North Carolina Business • Jul 22, 2020
WCTI 12 North Carolina News Eighth case of COVID-19 announced in North Carolina Triangle • Mar 12, 2020
The Citizen Times Asheville NC officials: 5 more coronavirus cases for 7 total statewide Mountains • Mar 10, 2020
WS Journal | State 5 more NC coronavirus cases reported, for 7 total statewide, state officials say North Carolina • Mar 10, 2020
The Daily Record | Dunn 5 more people test positive for COVID-19 in Wake County Sandhills NC • Mar 10, 2020
Triangle Business Journal Five coronavirus cases in Wake County linked to Biogen meeting in Boston North Carolina Business • Mar 10, 2020
The North State Journal | Raleigh Five more cases of coronavirus identifed in N.C. Triangle • Mar 9, 2020
WITN Greenville Five more people in North Carolina test positive for COVID-19 Inner Banks • Mar 9, 2020
WCTI 12 North Carolina News Five in NC test positive for coronavirus after attending Boston conference North Carolina • Mar 9, 2020
Triangle Business Journal Biogen's coronavirus cases rise, implicating another Boston health care event North Carolina Business • Mar 9, 2020
Triangle Business Journal Biogen pays California biotech $350M upfront for Alzheimer's gene therapy North Carolina Business • Feb 28, 2020
Triad Business Journal In Biogen, pharmaceutical industry could see first new Alzheimer's drug in years North Carolina Business • Dec 27, 2019
Triangle Business Journal 2020 Vision: In Biogen, industry could see first new Alzheimer's drug in years North Carolina Business • Dec 26, 2019
Triangle Business Journal In reversal, Biogen to file for approval of Alzheimer's drug North Carolina Business • Oct 23, 2019
Triangle Business Journal Biogen stock plummets after it abandons Alzheimer's drug North Carolina Business • Mar 21, 2019